Stocks and Investing Stocks and Investing
Fri, March 15, 2024

Derek Archila Maintained (ASND) at Buy with Increased Target to $260 on, Mar 15th, 2024


Published on 2024-10-28 09:43:24 - WOPRAI, Derek Archila
  Print publication without navigation


Derek Archila of Wells Fargo, Maintained "Ascendis Pharma A/S" (ASND) at Buy with Increased Target from $196 to $260 on, Mar 15th, 2024.

Derek has made no other calls on ASND in the last 4 months.



There are 4 other peers that have a rating on ASND. Out of the 4 peers that are also analyzing ASND, 0 agree with Derek's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Derek


  • Andreas Argyrides of "Wedbush" Maintained at Buy with Increased Target to $225 on, Thursday, February 8th, 2024
  • David Lebowitz of "Citigroup" Maintained at Strong Buy with Increased Target to $182 on, Thursday, February 8th, 2024
  • Li Watsek of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $173 on, Tuesday, February 6th, 2024
  • Kelly Shi of "Jefferies" Initiated at Strong Buy and Held Target at $150 on, Wednesday, December 20th, 2023
Contributing Sources